Webinar: Improving vaccine production through advanced raw materials for cell-based processes
Webinar details January 29, 2026 The production of cell-based vaccines demands robust, contamination-free upstream processes to ensure product safety, regulatory compliance and manufacturing efficiency. However, identifying high-quality, animal-free raw materials that consistently perform across established cell systems remains a key challenge for vaccine manufacturers. In this webinar, we will present validated solutions using recombinant insulin […]
Webinar: Ensuring compliance with animal-free raw materials in CGT
Webinar details November 20, 2025 The production of cell and gene therapies requires strict adherence to regulatory standards that ensure patient safety and product consistency. However, sourcing high-performing, animal-free raw materials that meet these standards remains a major challenge for many manufacturers. In this webinar, we will share validated solutions using Recombinant Insulin and Trypsin […]
Enhancing efficiency and safety in upstream biomanufacturing
Webinar details March 19, 2025 The use of animal-free reagents in the upstream manufacturing of biologic drugs is a common standard in biomanufacturing, essential for enhancing consistency and safety. Insulin has emerged as a key component in cell culture for biomanufacturing, improving a wide array of processes such as monoclonal antibody (mAb) production in CHO […]
Accelerate the scale-up to clinical phase: Optimizing stem cell culture performance and viral vector titers
Enhancing process efficiency with high-quality animal-free ingredients
Case study – Boost the production of monoclonal antibodies in CHO cells
Case study- Increase the viral vector production in HEK293 cells
Recombinant Insulin is the essential cell culture ingredient to boost cell proliferation and productivity
Effect of Insulin on influenza virus production in HEK293 Cells
Mammalian cells are considered an alternative to eggs for the production of influenza vaccines. HEK293SF-3F6 is a suspension GMP cell line that grows in serum-free media, and influenza production has been achieved in flasks and large bioreactors. To boost influenza production, insulin was added to the cultures. This growth factor was chosen because it has […]
